Skip to Content
U.S. National Institutes of Health
Last Updated: 03/05/10

Step 3 — Preliminary evaluation of clinical usefulness

  • What clinical question is the marker intended to address? Diagnosis, prognosis, prediction of response, disease monitoring, etc.?
  • Is the sensitivity or the accuracy of the assay adequate to address the clinical question? Does the marker correlate with other measures used in the same clinical setting? Does it provide additional information?